Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision

被引:6
|
作者
Mackintosh, John A. [1 ,2 ]
Keir, Gregory [3 ]
Troy, Lauren K. [4 ,5 ]
Holland, Anne E. [2 ,6 ,7 ]
Grainge, Christopher [8 ]
Chambers, Daniel C. [1 ,2 ]
Sandford, Debra [2 ,9 ,10 ]
Jo, Helen E. [4 ,5 ]
Glaspole, Ian [2 ,11 ]
Wilsher, Margaret [12 ]
Goh, Nicole S. L. [13 ,14 ,15 ]
Reynolds, Paul N. [2 ,9 ,10 ]
Chapman, Sally [16 ]
Mutsaers, Steven E. [17 ]
de Boer, Sally [12 ]
Webster, Susanne [4 ]
Moodley, Yuben [2 ,16 ,17 ]
Corte, Tamera J. [2 ,4 ,5 ]
机构
[1] Prince Charles Hosp, Dept Resp Med, Brisbane, Qld 4035, Australia
[2] Ctr Res Excellence Pulm Fibrosis, Camperdown, NSW, Australia
[3] Princess Alexandra Hosp, Dept Resp Med, Brisbane, Qld, Australia
[4] Royal Prince Alfred Hosp, Dept Resp & Sleep Med, Camperdown, NSW, Australia
[5] Univ Sydney, Sydney, NSW, Australia
[6] Alfred Hosp, Dept Physiotherapy, Melbourne, Vic, Australia
[7] Monash Univ, Cent Clin Sch, Dept Resp Res Alfred, Melbourne, Vic, Australia
[8] John Hunter Hosp, Dept Resp Med, Newcastle, NSW, Australia
[9] Cent Adelaide Local Hlth Network, Dept Thorac Med, Adelaide, SA, Australia
[10] Univ Adelaide, Adelaide, SA, Australia
[11] Alfred Hosp, Dept Resp Med, Melbourne, Vic, Australia
[12] Te Toka Tumai Auckland, Dept Resp Med, Auckland, New Zealand
[13] Austin Hosp, Dept Resp Med, Melbourne, Vic, Australia
[14] Inst Breathing & Sleep, Melbourne, Vic, Australia
[15] Univ Melbourne, Melbourne, Vic, Australia
[16] Univ Western Australia, Inst Resp Hlth, Nedlands, WA, Australia
[17] Fiona Stanley Hosp, Dept Resp Med, Murdoch, WA, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
idiopathic pulmonary fibrosis; interstitial lung disease; progressive pulmonary fibrosis; pulmonary fibrosis; treatment; INTERSTITIAL LUNG-DISEASE; OBSTRUCTIVE SLEEP-APNEA; QUALITY-OF-LIFE; PALLIATIVE CARE; ACUTE EXACERBATION; DOUBLE-BLIND; INTERNATIONAL SOCIETY; GASTROESOPHAGEAL-REFLUX; TELOMERE LENGTH; CLINICAL CHARACTERISTICS;
D O I
10.1111/resp.14656
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA) published a position statement on the treatment of IPF. Since that time, subsidized anti-fibrotic therapy in the form of pirfenidone and nintedanib is now available in both Australia and New Zealand. More recently, evidence has been published in support of nintedanib for non-IPF progressive pulmonary fibrosis (PPF). Additionally, there have been numerous publications relating to the non-pharmacologic management of IPF and PPF. This 2023 update to the position statement for treatment of IPF summarizes developments since 2017 and reaffirms the importance of a multi-faceted approach to the management of IPF and progressive pulmonary fibrosis.
引用
收藏
页码:105 / 135
页数:31
相关论文
共 50 条
  • [1] Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
    Jo, Helen E.
    Troy, Lauren K.
    Keir, Gregory
    Chambers, Daniel C.
    Holland, Anne
    Goh, Nicole
    Wilsher, Margaret
    De Boer, Sally
    Moodley, Yuben
    Grainge, Christopher
    Whitford, Helen
    Chapman, Sally
    Reynolds, Paul N.
    Glaspole, Ian
    Beatson, David
    Jones, Leonie
    Hopkins, Peter
    Corte, Tamera J.
    [J]. RESPIROLOGY, 2017, 22 (07) : 1436 - 1458
  • [2] Treatment of Idiopathic Pulmonary Fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia (vol 22, pg 1436, 2017)
    Jo, Helen
    Troy, Lauren
    Keir, Greg
    Chambers, Daniel
    Holland, Anne
    Goh, Nicole
    Wilsher, Margaret
    de Boer, Sally
    Moodley, Yuben
    Grainge, Chris
    Whitford, Helen
    Chapman, Sally
    Reynolds, Paul
    Glaspole, Ian
    Beatson, David
    Jones, Leonie
    Hopkins, Peter
    Corte, Tamera
    [J]. RESPIROLOGY, 2018, 23 (01) : 116 - 116
  • [3] Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary
    Jo, Helen E.
    Prasad, Jyotika D.
    Troy, Lauren K.
    Mahar, Annabelle
    Bleasel, Jane
    Ellis, Samantha J.
    Chambers, Daniel C.
    Holland, Anne E.
    Lake, Fiona R.
    Keir, Gregory
    Goh, Nicole S.
    Wilsher, Margaret
    De Boer, Sally
    Moodley, Yuben
    Grainge, Christopher
    Whitford, Helen M.
    Chapman, Sally A.
    Reynolds, Paul N.
    Beatson, David
    Jones, Leonie J.
    Hopkins, Peter
    Allan, Heather M.
    Glaspoley, Ian
    Cortey, Tamera J.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2018, 208 (02) : 82 - +
  • [4] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [5] Recommendations for the management of idiopathic pulmonary fibrosis in South Africa: a position statement of the South African Thoracic Society
    Koegelenberg, Coenraad F. N.
    Ainslie, Gillian M.
    Dheda, Keertan
    Allwood, Brian W.
    Wong, Michelle L.
    Lalloo, Umesh G.
    Abdool-Gaffar, Mohamed S.
    Khalfey, Hoosain
    Irusen, Elvis M.
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : 3711 - 3719
  • [6] Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis
    Behr, Juergen
    Bonella, Francesco
    Frye, Bjoern C.
    Guenther, Andreas
    Hagmeyer, Lars
    Henes, Joerg
    Klemm, Philipp
    Koschel, Dirk
    Kreuter, Michael
    Leuschner, Gabriela
    Nowak, Dennis
    Prasse, Antje
    Quadder, Bernd
    Sitter, Helmut
    Costabel, Ulrich
    [J]. PNEUMOLOGIE, 2023, 77 (02): : 94 - 119
  • [7] Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Liu, Gabrielle Y.
    Budinger, G. R. Scott
    Dematte, Jane E.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [8] Antifibrotic therapy for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Teoh, A.
    Glenn, L.
    Corte, T.
    Holland, A.
    [J]. RESPIROLOGY, 2023, 28 : 202 - 202
  • [9] IDIOPATHIC PROGRESSIVE PULMONARY FIBROSIS
    DAVIES, D
    CROWTHER, JS
    MACFARLANE, A
    [J]. THORAX, 1975, 30 (03) : 316 - 325
  • [10] Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*
    McDonald, Christine F.
    Jones, Stuart
    Beckert, Lutz
    Bonevski, Billie
    Buchanan, Tanya
    Bozier, Jack
    Carson-Chahhoud, Kristin, V
    Chapman, David G.
    Dobler, Claudia C.
    Foster, Juliet M.
    Hamor, Paul
    Hodge, Sandra
    Holmes, Peter W.
    Larcombe, Alexander N.
    Marshall, Henry M.
    McCallum, Gabrielle B.
    Miller, Alistair
    Pattemore, Philip
    Roseby, Robert
    See, Hayley, V
    Stone, Emily
    Thompson, Bruce R.
    Ween, Miranda P.
    Peters, Matthew J.
    [J]. RESPIROLOGY, 2020, 25 (10) : 1082 - 1089